ACL BFR: Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation

Sponsor
University of Colorado, Denver (Other)
Overall Status
Recruiting
CT.gov ID
NCT05735236
Collaborator
(none)
78
1
2
24
3.2

Study Details

Study Description

Brief Summary

The aim of this study is to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following knee arthroscopy.

Condition or Disease Intervention/Treatment Phase
  • Device: BFR Cuff
N/A

Detailed Description

The aim of this study is to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following knee arthroscopy. The current standard of care and post-operative pain levels can limit patients from applying load necessary to increase muscle size and strength development due to partial weight baring after surgery. We hypothesize that immediate and consistent use of BFR augmenting our current standard post operative knee arthroscopy rehabilitation protocol will result in greater improvement in strength and quicker achievement of phase-based rehabilitation goals. We hypothesize that these objective improvements in strength will correlate with clinically meaningful improvement in Tegner activity scale, International Knee Documentation Committee (IKDC), return to sport, Lower Extremity Functional Scale (LEFS), pain and resiliency (patient reported outcome, PRO) scores indicative of greater functional recovery compared to our standard rehabilitation protocol alone.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation
Actual Study Start Date :
Nov 8, 2022
Anticipated Primary Completion Date :
Nov 8, 2024
Anticipated Study Completion Date :
Nov 8, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Participants undergo standard post-operative physical therapy as prescribed by their surgeon.

Active Comparator: BFR Cuff

Patients undergo standard post-operative physical therapy as prescribed by their surgeon with the addition of a Blood Flow Restriction (BFR) cuff that is used during their exercises.

Device: BFR Cuff
The BFR cuff will be applied to the proximal thigh of the surgical leg while the patient completes specified physical therapy exercises.80% occlusion pressure will be determined by PT's in clinic through the use of a Delphi unit. Subjects will then be able to use the Saga Fitness app to adjust this pressure if it differs from the automatic calibrated pressure.
Other Names:
  • Blood Flow Restriction Device
  • Blood Flow Restriction Cuff
  • Outcome Measures

    Primary Outcome Measures

    1. Knee extensor strength [6 months]

      Strength of knee extensors via handheld dynamometry (HHD) and reported as a measure of limb symmetry index (LSI) comparing operative limb to non-operative lim

    Secondary Outcome Measures

    1. hamstrings musculature strength [6 months]

      Strength of knee flexors via handheld dynamometry (HHD) and reported as a measure of limb symmetry index (LSI) comparing operative limb to non-operative limb.

    2. single leg squat test [6 months]

      Performance on a Repeated Single Leg Squat test to 45 deg knee flexion over the course of 90 seconds reported as a measure of LSI

    3. Tegner Activity Scale [6 months]

      Tegner Activity Scale: Range 0 (disability because of knee problems) - 10 (national or international level soccer)

    4. LEFS [2 years]

      Range 0 (extreme difficulty) -100 (nodifficulty);MDIC = Δ 123

    5. Pain NPRS [2 Years]

      Range 1 (low pain) -10 (high pain); MDC = Δ 34

    6. PROMIS Pain [2 Years]

      Range 0 (low pain) -100 (highpain); MDC = Δ 85

    7. PROMIS Physical Function [2 Years]

      Range 0 (low function) -100 (high function); MDC = Δ 85

    8. Brief Resiliency Score (BRS) [2 Years]

      Range 1(low resilience) -5 (high resilience); MDC = Δ low (1-2.99) to normal (3-4.3) to high (4.31-5)

    9. ACL-RSI [2 Years]

      Range 1 (low function) -100 (high function); MDC = ∆15.1 for short form version

    10. IKDC [2 Years]

      Range 1 (low function) -100 (high function); MDC = ∆8.8 low to ∆15.6 high

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with ACL reconstruction with quadriceps, hamstring, bone-patellar-bone or allograft graft, with/without meniscectomies. Patients must also have access to a smartphone device in order to utilize the SAGA BFR application for use. The application is free to use.
    Exclusion Criteria:
    • Bilateral knee surgeries to be performed within 12 weeks of each other, meniscus repairs, chondral lesion repair/transplants, ACL revisions that utilize contralateral autografts, MCL repairs, and the following BFR contraindications: deep vein thrombosis (DVT), pulmonary embolism, hemorrhagic/thrombolytic stroke, clotting disorders, hemophilia or taking blood thinners, pregnant or up to 6 months postpartum, untreated hypertension, untreated hypotension, rhabdomyolysis or recent traumatic injury, does not understand English, and the following BFR contraindications:
    1. Contraindications for BFR
    • Deep Vein Thrombosis (DVT)

    • Pulmonary Embolism

    • Hemorrhagic/Thrombolytic Stroke

    • Clotting Disorders

    • Hemophilia or taking blood thinners

    • Pregnant or up to 6 months post-partum

    • Untreated Hypertension

    • Untreated Hypotension

    • Rhabdomyolysis or recent traumatic injury

    1. Exclusion criteria will be evaluated via the medical record as well as by the expert opinion of the physician.

    2. If at any point in the study a subject develops one of the above contraindications, they will be removed from the study.

    3. If a subject becomes pregnant while participating in the intervention portion of the study, they will be removed.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UCHealth Steadman Hawkins Clinic Centennial Colorado United States 80111

    Sponsors and Collaborators

    • University of Colorado, Denver

    Investigators

    • Principal Investigator: James Genuario, MD, University of Colorado, Denver

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    University of Colorado, Denver
    ClinicalTrials.gov Identifier:
    NCT05735236
    Other Study ID Numbers:
    • 22-1052
    First Posted:
    Feb 21, 2023
    Last Update Posted:
    Feb 21, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 21, 2023